CARL ZEISS MEDITEC AG
Commented by André Will-Laudien on January 28th, 2026 | 07:15 CET
Silver soon at USD 200? Buying at elevated levels or seizing opportunities with CSG, American Atomics, and Carl Zeiss Jena
After a nervous start to the year, commodities and energy issues are once again firmly in focus on global capital markets. Recent discussions around trade tariffs and geopolitical dependencies, topics that also dominated the World Economic Forum in Davos, have triggered pronounced volatility. At the same time, heightened volatility is opening up attractive opportunities for investors. Whether silver, copper, nickel, lithium, or uranium, these metals are essential for industry, the energy transition, and electromobility. Their growing strategic importance is driving up prices and increasingly acting as an inflationary force in Western economies. The underlying factors include disrupted supply chains, export-policy uncertainties, and a tight structural supply deficit. In China, for example, solar module manufacturers are reportedly beginning to stockpile silver, as physical material is becoming increasingly difficult to source. As a result, the price of silver has multiplied within just one year, and physical demand now significantly exceeds global annual production. Investors should take note.
Read
Commented by Armin Schulz on October 2nd, 2024 | 07:00 CEST
Evotec, Nyxoah, Carl Zeiss Meditec – Biotech and medtech stocks with potential
The biotechnology and medical technology industries are driving medical innovation and offering exciting investment opportunities. Evotec, Nyxoah, and Carl Zeiss Meditec stand out among the companies that are particularly prominent in these areas. Evotec has established itself through its collaborative strategy in drug discovery and is using modern technologies such as AI to accelerate the discovery process. The emerging medtech company Nyxoah is focusing on innovative solutions for the treatment of sleep apnea. Carl Zeiss Meditec is a leader in ophthalmology and microsurgery with world-class optical devices and advanced visualization technologies. All three companies have recently seen their stock prices come under pressure and now offer an entry opportunity.
Read